Download barts and the london nhs trust

BARTS AND THE LONDON NHS TRUST
Recruitment Material
For the Post of
Consultant Clinical Oncologist
Part 1: Job Description
Part 2: The Trust, the Cancer Clinical Academic Unit
and the Clinical Oncology Department
Person Specification
Job Reference Number:
Closing Date: 25 September 2008
BARTS AND THE LONDON NHS TRUST
CONSULTANT CLINICAL ONCOLOGIST
JOB DESCRIPTION
SUMMARY:
The advertised post is for a Consultant in the Department of Radiotherapy / Clinical
Oncology at the Barts and the London NHS Trust. The post will be based at St
Bartholomew’s Hospital and includes a commitment to support the Oncology Service at
Newham University Hospital NHS Trust. The successful candidate will join existing sitespecialist multidisciplinary teams in the fields of breast and skin cancer and will share
responsibility with seven colleagues for the running of the Trust’s Clinical Oncology
service and training programme. This is a replacement appointment with a revised job
plan reflecting service restructure.
The successful candidate will be encouraged to undertake collaborative research with
colleagues in the Institute of Cancer.
The successful candidate will need to demonstrate professional excellence and the
ability to deliver effective care. He/she will need to agree a job plan with the Clinical
Academic Unit Director and review this on an annual basis in the light of service
development and changes in activity levels.
The successful candidate will be required to adhere to the Trust’s policy on maintaining
medical excellence and to be committed to maintaining their standard of performance
by keeping their knowledge and skills up to date.
2
BARTS AND THE LONDON NHS TRUST
CONSULTANT IN CLINICAL ONCOLOGY
JOB DESCRIPTION
General duties of the post

To contribute to the provision of a comprehensive, efficient and high quality
evidence-based Clinical Oncology service, with continuing responsibility for the
care of patients in his/her charge, including all administrative duties associated
with patient care.

Leadership, development and organisation of the services in his/her charge in
line with Trust / Divisional business plans. Full participation in the management of
the Cancer Clinical Academic Unit (CAU) and Department of Radiotherapy /
Clinical Oncology. Liaison and communication with the Clinical Academic Unit
Director and General Manager and with the Director and Head of Operations of
the Regional Services Division.

To develop his/her own interests and specialities within oncology, including
active participation in research programmes.

Corporate and individual responsibility for the professional management of
doctors in training.

To have regard at all times to the clinical and quality standards set out in the
NHS Cancer Plan, the Improving Outcomes reports and National Institute for
Clinical Excellence (NICE) guidance reports.

To liaise effectively and on a timely basis with General Practitioners, community
services, and all healthcare agencies.

To maintain and promote team and multidisciplinary work.

To participate in the consultant on-call rota.

To participate fully in the preparation for and representation at peer review site
visits.

To engage fully in the annual job planning and appraisal cycle and to contribute
to the appraisal of doctors in training
3
Specific duties of the post at Barts and the London Hospitals NHS Trust

To provide, with colleagues, day to day care and supervision of oncology
inpatients as part of the multi-disciplinary team.

To provide, with colleagues, a referral service for inpatients under the care of
other clinical departments in the Trust, who are diagnosed with or develop
cancer-related complications during their inpatient stay.

To provide, with colleagues, an emergency referral service for inpatients at other
hospital sites within the North East London Cancer Network who develop cancerrelated complications during their inpatient stay.

To provide, with colleagues, clinical care and supervision of the radiotherapy
facilities and patients.

To provide, with colleagues, clinical care and supervision of patients attending
the Paget Oncology Day Unit.

To provide the Clinical Oncology support at Barts to the BLT and Homerton
University Hospital Breast Units.

To be the clinical lead for skin malignancies within the Clinical Oncology
department and to provide the Clinical Oncology specialist input to Trust’s Skin
Cancer Multidisciplinary Team (MDT), attending the weekly MDT case-review
meetings and combined specialist clinic. To provide a referral service for the
management of skin malignancies to other hospitals within the North East
London Cancer Network. To support the Network skin cancer Tumour Advisory
Board.

To contribute to the Clinical Oncology department’s research and development
programme, in particular, the implementation of intensity-modulated radiotherapy
and the establishment of Barts as a centre for the development of image-guided
radiotherapy.
Specific duties of the post at Newham University Hospital NHS Trust

To contribute to the development and provision of a comprehensive, efficient and
high quality Oncology service.

To provide specialist Clinical Oncology support for the breast cancer service
working in the multidisciplinary team and in liaison colleagues at Barts. To
provide input from the Newham service in to the Network Breast Tumour
Advisory board.

To provide, with colleagues, a referral service for inpatients under the care of
other clinical departments in the Trust, who are diagnosed with or develop
cancer-related complications during their inpatient stay.
4

To provide, with colleagues, clinical care and supervision of patients attending
the Chemotherapy Day Unit, including cover for oncology colleagues who are off
site on a Wednesday afternoon.

To participate in the education of postgraduate doctors within the Trust and to
assist with teaching non-medical personnel as appropriate. The appointee will
contribute to academic meetings where appropriate.
On-call commitment
The appointee will participate in the on-call rota for the Clinical Oncology service at
Barts and the London and the period of on call will coincide with covering Clinical
Oncology inpatients at Barts. The rota is 1:6 evenings and weekends (category B),
currently arranged on a week-on basis Friday-Friday. This results in a percentage
supplement on the basic salary of 2%.
The frequency of the on-call commitment is unlikely to change (without a change in the
consultant establishment) but the rota timetable may be subject to change in the future.
Accountability
The appointee will have full professional independence on medical matters but will be
managerially accountable to the Trust and the Chief Executive, through his/her CAU
Director.
Clinical Governance
The appointee is expected to participate in the Trust’s clinical effectiveness activities,
and to encourage and foster improvements in the quality and standards of clinical
services. The appointee will assist with the safeguarding of high standards of care by
participating in the creation of an environment in which excellence in clinical care will
flourish.
Continuing Professional Development and Continuing Medical Education
The appointee is expected to take responsibility for their own continuing professional
development (CPD) and take part in continuing medical education activities (CME), in
line with the requirements of the Royal College of Radiologists’ guidelines to maintain
standards of performance and in consultation with the CAU Director
The appointee will be expected to be committed to the concept of lifelong learning and
produce and maintain a personal development plan in agreement with their CAU
Director
Study leave is available as provided for under the Terms and Conditions of Service for
Consultants (England) 2003 and subject to the approval of the CAU Director / General
Manager.
5
Teaching and Training
The Trust is committed to sustaining and advancing the provision of medical, dental,
nursing and other professional education and to the delivery of high quality
postgraduate and undergraduate training.
The appointee will be expected to participate fully in the education of postgraduate
doctors within the Cancer CAU and where appropriate, across the Trust. This will
involve regular teaching commitments agreed with the CAU Director, and supervised by
the Unit Training Director.
The appointee will assist with the drawing up of training agreements for SHOs and
Clinical Oncology SpRs and with the delivery of training specified in the agreement.
The appointee will also assist with the teaching of medical students attached to the
department, and with teaching non-medical personnel as appropriate.
Teaching within the department includes regular presentations, and informal practical
and theoretical training sessions.
Research and Development
The appointee will be expected to participate actively in clinical and laboratory based
research programmes and initiatives, in co-operation with the Institute of Cancer, under
the guidance of the Research and Development department and within the guidelines of
Trust policies. The appointee will be encouraged to initiate his/her own research
projects. The appointee will be expected to maximise recruitment of patients to National
Cancer Research Network-accredited trials both at this Trust and at Newham University
Hospital NHS Trust.
Equal Opportunities
The appointee must at all times carry out responsibilities and duties with due regard to
the Trust’s Equal Opportunities Policy.
Health and Safety
The appointee is expected to undertake the appropriate management responsibilities,
and be aware of individual responsibilities in accordance with the Trust’s Health and
Safety policy and report as necessary, any untoward accident, incident or potentially
hazardous environment. The appointee will promote and implement the Health and
Safety Policy. The Trust operates a no smoking policy.
Salary and Conditions of Service
This appointment is subject to the Terms and Conditions of Service for Consultants
(England) 2003, to the General Whitley Council Conditions of Service and also to the
6
NHS Pension Scheme regulations. The illustrative job plan / timetable set out below are
in line with the Terms and Conditions of Service for Consultants (England) 2003.
The appointment is on a full time basis (i.e. an average of 10 programmed activities per
week). The present salary scale is £73,403 - £98,962 for 10 programmed activities.
Applicants must have completed specialist training in clinical oncology and be on the
Specialist Register before they take up this appointment.
The Trust requires the appointee to have and to maintain full registration with the
General Medical Council/Dental Council. Medical and dental staff are advised to
continue membership of a medical defence organisation.
The successful candidate will also receive a London Weighting allowance of £2,162 per
annum (London Zone).
Due to the nature of the work in this post, it is exempt from the provision of section 4 (2)
of the Rehabilitation of Offenders Act 1974, by virtue of the Rehabilitation of Offenders
Act 1974 (Exemption Order 1975).
Applicants are therefore not entitled to withhold information about convictions, including
those which, for other purposes are “spent”, under the provisions of the Act, and are
required to disclose convictions including those pending, to the Trust. Failure to disclose
such information may result in dismissal or disciplinary action.
The successful candidate will normally be required to live within 10 miles or 30 minutes
travelling time from the Trust.
Illustrative job plan and proposed timetable
This job plan is illustrative only and is in line with the Consultant Contract (England)
2003. It is subject to negotiation with the successful candidate and will be reviewed
annually by the CAU Director and the appointee.
The table shows timetable commitments (10 PAs) apportioned to direct clinical care
(DCC – 7.5 PAs) and supporting professional activity (SPA - 2.5 PAs).
Sessional commitments may be revised in the future by mutual agreement as the needs
of the service and the work patterns with oncology colleagues change.
7
Timing
Description
Frequency
Location
DCC/SPA
Average
weekly PAs
09-10
10-12
SPA
Ward round (with
CJG and RR)
SPA
SPA
Weekly
Weekly
Barts
Barts
SPA
DCC
0.25
0.5
Weekly
Weekly
Barts
Barts
SPA
SPA
0.25
1.0
0910.30
10.3014
14-17
Skin MDM
Weekly
RLH
DCC
0.375
Skin clinic + travel
Weekly
RLH
DCC
0.875
Radiotherapy
planning & ontreatment review
Weekly
SBH
DCC
0.75
08-12
12-18
Breast MDM
Outpatient clinic,
ward referrals &
admin.
Weekly
Weekly
Barts
Newham
DCC
DCC
1
1.5 (inc.
travel)
09-10
10-12
SPA
Ward round (with
CJG and RR)
SPA
Breast clinic (chemo
review and followup)
Weekly
Weekly
Barts
Barts
SPA
DCC
0.25
0.5
Weekly
Weekly
Barts
Barts
SPA
DCC
0.5
0.75
Oncology radiology
review meeting
Breast Clinic (new
patients*) and
admin.
RT volume /image
review / admin.
Weekly
Barts
SPA
0.25
Weekly
Barts
DCC
0.75
Weekly
Barts
DCC
0.5
Monday
12-13
13-17
Tuesday
Wednesday
Thursday
12-14
14-17
Friday
08.15 –
09.15
09.15 –
12.30
12.3014.30
CJG = Dr Chris Gallagher, Consultant Medical Oncologist
RR = Dr Rebecca Roylance, Consultant Medical Oncologist
*new patients include radiotherapy referrals from the Homerton Breast Unit
DCC = Direct clinical care
SPA = supporting professional activity – teaching, audit, management, research, service development
Inpatient care
Oncology inpatient care at Barts is site-specialist team-based and the appointee will
work with Drs Rebecca Roylance and Chris Gallagher (with oncology SpRs and wardbased trainees) in managing breast cancer inpatients. It is anticipated that there will be
very few dermatology oncology inpatients and these will be managed on an ad hoc
basis by the appointee, in conjunction with Dr Peter Szlosarek, the SpR and wardbased trainees.
8
Anticipated workload
The Breast MDM at Barts reviews approximately 350 new breast cancer (including in
situ) diagnoses per annum (from Barts, Homerton and Newham Hospitals). In addition
to supervising radiotherapy where appropriate, the appointee will work with Drs
Gallagher, Roylance and Slater in the delivery of adjuvant and palliative systemic
therapy to this patient population. At present, the Dr Wells treats less than 50 patients
with skin malignancies per annum but there is ample opportunity to develop this practice
further.
Office accommodation and secretarial support
The appointee will have office accommodation in the Radiotherapy Department at Barts
with an Aria workstation and computer terminal for access to the Trust Clinical Record
System (CRS) plus PACS and the Cancer Clinical Information System. Full time
secretarial support is provided.
Hepatitis B and HIV/AIDS policy
Prior to employment the Trust will require you to undertake a medical examination
which will include Hepatitis B screening. The BMA code of conduct in case of doctors
who have HIV infection / AIDS should be followed. In such cases the Trust expects all
doctors to make disclosure to the Occupational Health Physicians whether they will be
undertaking invasive procedures or not.
Other aspects of the post / additional Information
This job description is an outline only. It is not exhaustive and may be altered from time
to time in accordance with the needs of the service, following negotiation with the
appointee. The appointee will be required to be co-operative and flexible in accordance
with the needs of the service.
In addition to their commitment to on-going patient care and the supporting professional
activities outlined on the preceding pages, all consultants at this Trust have a continuing
responsibility for the smooth functioning of their department / CAU and the efficient
management of its resources. This includes the provision of adequate cover for
colleagues on leave by mutual agreement.
Further information from:
Prospective candidates are encouraged to visit both hospital Trusts, which may be
arranged by contacting one of the following:
Dr Nick Plowman, Lead Consultant Clinical Oncologist, Barts Hospital
Secretary: 020 7601 8351
email: [email protected]
9
Dr Chris Cottrill, Consultant Clinical Oncologist, Barts Hospital
Secretary: 020 7601 8355
email: [email protected]
Dr Clare Phillips, Consultant Physician in Palliative Care, Barts and the London NHS
Trust and Clinical Lead for Cancer at Newham University Hospital NHS Trust
Secretary: 020 7601 8500
Email: [email protected]
10
BARTS AND THE LONDON NHS TRUST
CONSULTANT IN CLINICAL ONCOLOGY
Part 2: The Trust and the Clinical Academic Unit
General Information
The appointee will be expected to work closely with the Clinical Academic Unit (CAU)
Director and the General Manager in the management and administration of resources
and to be active in promoting changes which improve the delivery of care to patients.
Barts and the London NHS Trust
Barts and The London is one of Britain’s top teaching hospital trusts. Our mission is to
bring excellence to life – to give patients the best possible care so that they can live
better, fuller, longer lives.
Every year we care for over 500,000 people from the City, East London and beyond –
communities with a rich ethnic, religious and cultural diversity; from the affluent finance
and business centres of the City and Docklands, to the vibrant Bangladeshi community
in and around London’s Brick Lane.
The Trust is made up of the following teaching hospitals:



The Royal London Hospital in Whitechapel
St Bartholomew's Hospital (Barts) in the City of London
The London Chest Hospital in Bethnal Green.
Barts and The London is organised into three divisions (Acute and Family Services;
Regional Services; Clinical and Diagnostic Services) under the leadership of the Chief
Executive, Mr Julian Nettel.
Each Division is headed by a Divisional Director (Dr Celia Skinner in the case of
Regional Services) supported by a Divisional Head of Operations (Ms Julie Lamb for
Regional Services) and a Divisional Senior Nurse.
The Divisions comprise a varying number of Clinical Academic Units. The Cancer
Clinical Academic Unit lies in the Regional Services Division.
The Divisional Directors, supported by Operational Managers and CAU Directors, are
responsible for the day-to-day management and the running of the Trust's services,
while the Trust Board (comprising full-time executive directors and part-time nonexecutive directors) is accountable for setting the strategic direction of the Trust,
monitoring performance against objectives, ensuring high standards of corporate
governance and helping to promote links between the Trust and the local community.
11
The New Hospitals Project
Construction work is at an advanced stage to build Britain’s biggest new hospital on the
Royal London Hospital site in Whitechapel and to redevelop Barts Hospital as a Cancer
and Cardiac Centre of Excellence. The £1 billion private finance initiative development
is being carried out by the Skanska Innisfree John Laing consortium. The entire
redevelopment of both hospitals is expected to be completed in 2015. The new Cancer
Centre at Barts is due to open in 2010 and most new facilities at The Royal London
should be operational early in 2012.
Barts and the London Cancer Centre and the Institute of Cancer
Barts and The London Cancer Centre (www.bartsandthelondon.nhs.uk/cancercentre) is
based at Barts Hospital in the City of London. The centre is a major tertiary referral
centre for all forms of malignant disease in adults, providing cancer services to a
population of more than one and a half million people in East London and the City. Our
new hospitals programme will create a purpose-built Cancer and Cardiac Centre of
Excellence at Barts, providing facilities to improve the high standard of clinical care that
patients already receive.
In conjunction with the Institute of Cancer at Barts and the London, Queen Mary’s
School of Medicine and Dentistry (www.cancer.qmul.ac.uk) our mission is to establish a
major international centre of excellence in both cancer research and clinical cancer care
on the West Smithfield site at Barts Hospital and in Charterhouse Square.
Our clinical and research teams were awarded Experimental Cancer Medicine Centre
(ECMC) status by the Department of Health and Cancer Research UK and our
Experimental Cancer Unit was recently opened at the Barts site.
We are the specialist regional centre for cancer treatment in north east London and
belong to the North East London Cancer Network together with Homerton, Newham,
Whipps Cross, King George Ilford, and Queens Hospitals. The Cancer Centre provides
an outreach service to each of these hospitals, (and for some services, e.g. melanoma,
to an extended network of additional hospitals.
Cancer Clinical Academic Unit
The Director and General Manager share responsibility for the overall performance of
the CAU which comprises:






Radiotherapy / Clinical Oncology
Medical Oncology (solid tumours)
Haematology Oncology
Palliative Care
Breast Surgery
Gynaecological Oncology
12

Ophthalmology
With the exception of the paediatric service (which is based on the Whitechapel site) all
cancer treatment is administered at Barts.
Director of Cancer Clinical Academic Unit
Professor Nicholas Lemoine MD PhD FRCPath FMedSci
Director of the Institute of Cancer and Cancer Research UK Clinical Centre
Barts and the London School of Medicine and Dentistry
Contact: [email protected]
Clinical Lead for Solid Tumour Oncology
Dr Chris Cottrill BSc PhD MRCP FRCR
Consultant Clinical Oncologist
Acting General Manager for Cancer Clinical Academic Unit
Mrs Kay Cuming
The Medical Oncology consultant staff comprises:
Haematology Oncology
Dr J Cavenagh MD FRCP FRCPath (Clinical Lead)
Professor T A Lister BA(Hons) FRCP FRCPath FRCR
Professor A Z S Rohatiner MD FRCP
Professor J Gribben MD DSc FRCPath FRCP FMedSci
Dr S Agrawal BScPhD MRCP MRCPath (Senior Lecturer, Honorary Consultant)
Dr S Montoto MD (Senior Lecturer, Honorary Consultant)
Dr H Oakervee MD MRCP MRCPath (Senior Lecturer, Honorary Consultant)
Dr D Taussig PhD MRCP MRCPath (Senior Lecturer, Honorary Consultant)
Solid Tumours
Dr C Gallagher BSc PhD FRCP (breast, gynaecology)
Professor I McNeish PhD MRCP (gynaecology) (Clinical Academic)
Dr Tom Powles MD MRCP (GU) (Clinical Academic)
Dr D Propper MD FRCP (GI, hepatobiliary)
Dr R Roylance PhD MRCP (breast) (Clinical Academic)
Dr J Shamash MD MRCP (urology, lung)
Dr S Slater MD MRCP (GI, hepatobiliary, breast)
Dr P Slosarek PhD MRCP (skin, lung) (Clinical Academic)
Dr J Steele MD MRCP (lung, GI)
Inpatient and day-case facilities
13
There are 45 solid tumour oncology beds on Rahere and Gordon Hamilton Fairley
Wards at Barts. Inpatients are managed by site-specialist clinical teams comprising
both clinical and medical oncology consultants.
The Bodley Scott Wards comprise 35 beds for haematological malignancies and for
patients receiving myeloablative therapy. There are no adult oncology inpatient beds at
the Royal London Hospital.
In addition to the inpatient wards we have the Gloucester House hostel, which can
accommodate 12 self-caring ambulatory patients.
The Paget Oncology Day Unit treats approximately 35 patients per day. All
chemotherapy is prescribed electronically using the Varian MedOnc system. We
anticipate that this will be fully integrated with the radiotherapy Aria network in the
near future.
There are no dedicated palliative care beds. Patients are jointly managed with the team
led by Drs Clare Phillips, Teresa Tate and David Feuer (Clinical Lead) all Consultant
Physicians in Palliative Care.
Department of Radiotherapy / Clinical Oncology
The department is currently based in Bartholomew Close adjacent to the main hospital.
The new purpose-built department, already under construction behind the current King
George V block, has been designed through close collaboration between the clinical
oncologists, radiographers, physicists and the architects / PFI development team. It will
house six bunkers with five linear accelerators in addition to a purpose-built
brachytherapy suite in the main theatre complex.
The department was the first in the world to introduce megavoltage radiotherapy and is
an international leader in the field of linac-based stereotactic radiotherapy. Intensity
modulated radiation therapy (IMRT) is now part of routine clinical practice and we are
commissioning a recently-installed on-board imaging facility with a view to image-guided
radiation therapy (IGRT). In partnership with the private sector we service a
GammaKnife facility, soon to be relocated on the Barts site.
The department team comprises:
Medical Staff
Dr P N Plowman MA MD FRCP FRCR (CNS, endocrine)
Dr C P Cottrill BSc PhD MRCP FRCR (breast, GI, HIV)
Dr S Gibbs MRCP FRCR (GI, GU) [3 sessions at Barts]
Dr M E B Powell MD FRCP FRCR (gynaecology, head & neck, haematology) [3
sessions at Queen’s, Romford]
Dr A Sibtain MD MRCP FRCR (head & neck, GI)
Dr P Wells PhD MRCP FRCR (GU, lung)
2 year 4-5 Specialist Registrars
5 year 1-3 Specialist Registrars
14
In addition to the advertised post we are looking to appoint two clinical oncology
academic posts (each 0.5 clinical WTE), one with a specialist interest in genitourinary
cancer.
Physics, Dosimetry and Technical Staff (Radiotherapy Physics in Clinical and
Diagnostic Services Division)
Miss Christine Usher, Consultant Physicist
7 medical physicists
3.5 WTE dosimetrists
2 electronic engineers
3 workshop and mould room technologists
Radiography Staff
Radiotherapy Service Manager (Band 8c radiographer, to be appointed)
1 band 8b radiographer
2 band 8a radiographers
24 band 5-7 radiographers
Radiotherapy Nursing Staff
2 WTE band 7
1 Clinical Nurse Specialist
There are 5 full-time secretarial posts and 4 clerical staff.
Equipment
Varian Ximavision EX simulator with digital imaging, CT capability, external field display.
It is fully integrated in the department's Aria network
Two Varian 2100EX multiple energy linear accelerators with 120 leaf MLC, electronic
portal imaging and dynamic IMRT capability. One with on-board imaging.
Two Varian 600EX 6 MV single energy linear accelerator with 120 leaf MLC, electronic
portal imaging and dynamic IMRT capability.
All of the linear accelerators are on the Aria network.
Superficial / Orthovoltage Unit (60 kV, 120 kV, 300 kV)
Varian GammaMed HDR Unit (with Eclipse planning system). There full facilities to
support interstitial brachytherapy including iodine seed prostate brachytherapy.
Varian Eclipse treatment planning system workstations in the Physics Department,
planning suite and consultants' offices.
The department has dedicated time on a GE Advantage CT scanner within the
diagnostic radiology department. This staffed by therapy radiographers and is linked
directly to the department's treatment planning system. Images from the hospital's MRI
15
scanner can also be transmitted directly to this system allowing full use of image-fusion
technology within the Eclipse system. BrainLAB registration and fusion is used in
conjunction with Eclipse for stereotactic planning.
Full imaging facilities (64-slice PET-CT, CT and MRI) are available on the Barts site,
pathology services are based at Whitechapel with a satellite laboratory at Barts.
Outpatient clinics
The majority of the Clinical Oncology clinics (and most of the combined clinics) are held
in either the main outpatients suites or the West Wing on the Barts site.
Consultants from the Department hold peripheral clinics at Whipps Cross, King George
Ilford, Newham General, St Andrew’s Bow and the Homerton Hospitals. Drs Powell and
Gibbs have clinical sessions at both Queen’s Hospital, Romford and Barts.
Research interests and service development
The Department is an international leader in the field of Linac-based stereotactic
radiotherapy and with the collaborative GammaKnife venture we have a unique
opportunity to directly compare two stereotactic modalities within a single institution.
The Linac-based system now incorporates micro-MLC and a dynamic IMRT facility.
Barts has long been recognised for its pioneering work in the field of technical
radiotherapy and we fully intend to maintain this reputation. IMRT is now offered as a
routine clinical service for head and neck malignancies and we are looking to expand
the service to other tumour sites. We have an excellent working relationship with
colleagues in the Academic Radiology and Nuclear Medicine, with collaborative work in
the areas of image fusion for treatment planning, post-treatment imaging and
radionucleide therapy. With the recent commissioning of the 64-slice PET/CT we are
looking towards PET-therapy CT image fusion with its potential for target definition and
dose-painting.
In a collaborative venture with our colleagues at the Institute of Cancer we are
developing two new consultant clinical academic posts in Clinical Oncology /
Radiotherapy, one with a major interest in urological malignancies.
Barts and the London Skin Cancer Service
Barts and The London’s Skin Centre is one of the largest dermatology departments in
the UK and the second largest in London. In conjunction with the Cancer Centre all
forms of skin cancer are treated in a multidisciplinary setting. It is one of the few
centres in London offering sentinel node biopsy as the standard of care for melanoma
and other high risk skin malignancies.
The consultant team comprises:
Professor Rino Cerio, Consultant Dermatologist and Senior Clinician
Dr Catherine Harwood, Clinical Senior Lecturer and Honorary Consultant
Dermatologist
Dr Jane McGregor, Senior Lecturer and Honorary Consultant Dermatologist
Mr Graham Moir, Plastic Surgeon
16
Dr Peter Szlosarek, Cancer Research UK Clinician Scientist and Honorary
Consultant in Medical Oncology
Dr Paula Wells Consultant Clinical Oncologist (who will relinquish this role to the
appointee)
There is an active research programme in conjunction with the Cancer Research UK
Skin Tumour Laboratory based in the Centre for Cutaneous Research, Institute of Cell
and Molecular Science, Queen Mary University of London.
Among the main skin cancer research projects are:
Epidemiological and clinicopathological studies of skin cancer in organ transplant
recipients.
Prevention and treatment of transplant related skin cancer.
Genome wide genetic and epigenetic changes in SCC and precursors.
Role of human papillomavirus in SCC.
Genetics and signalling pathways in BCC.
Apoptosis and p53 pathogenesis of melanoma.
The role of azathioprine in transplant skin tumours.
The role of L-Arg/ASS in melanoma development.
Audit / Clinical Effectiveness
The CAU has a Clinical Effectiveness Working Group and programme of clinical
effectiveness meetings, which the appointee is expected to both attend and contribute
to.
CME and postgraduate education
Full library facilities exist on the Barts, Royal London and Charterhouse sites, including
Internet and Medline access. The majority of the national and international oncology
journals can be accessed. The Department has print / electronic subscriptions to the
radiotherapy/clinical oncology specialist journals.
As a Consultant group we are committed to maintaining the reputation of this institution
for oncology training. The department gives organisational and teaching support to the
Institute of Cancer Research Oncology MSc Course, with Radiotherapy Physics has
providing the backbone of the physics teaching. All our trainees attend the course, with
this time protected.
The year 1-3 SpRs rotate through 6-month attachments at Barts, Queen’s and
Southend Hospitals. Most trainees spend 18 months - 2 years at Barts. The appointee
will be expected to contribute to the regular appraisal of trainees.
In line with the IRMER Regulations, the year 1-3 SpRs are not permitted to direct
radiotherapy treatment (i.e. plan or prescribe) without the immediate supervision of a
Consultant or post-FRCR year 4-5 trainee.
Within the Department there is a weekly Journal Club (and a second in the Medical
Oncology department). There are regular weekly consultant-led case presentation
sessions and planning tutorials. The appointee will be encouraged to contribute to
17
these and to develop further formal teaching sessions. Across the CAU there is an
extensive timetable of multidisciplinary meetings and Research Seminars. The Medical
College holds weekly Grand Rounds on both sites.
Undergraduate education
The Medical College is a national leader in the development of a fully integrated basic
science and clinical medical course. Attachments to the oncology specialities form an
important component of the first clinical year. We have the opportunity to take final year
students for Special Study Modules (SSMs) and the appointee would be encouraged to
develop SSMs in their own areas of interest.
18
BARTS AND THE LONDON NHS TRUST
CONSULTANT IN CLINICAL ONCOLOGY
PERSON SPECIFICATION
Qualifications
Knowledge
Training Expected
Management/Audit
Experience
Academic
Achievements
Research Publications
Personal Skills
Personal Qualities
Essential
MB BS, or equivalent
MRCP(UK) , or
equivalent
FRCR (Therapy)
CCST in Clinical
Oncology (or within 3
months of date of
interview)
Broad based knowledge
of and understanding of
Clinical Oncology,
including radiotherapy,
chemotherapy and the
principles of palliative
care.
Specialist knowledge in
the management of
breast and skin
malignancies.
Higher Specialist
Training in Clinical
Oncology.
Experience in teaching /
training undergraduates
and postgraduates
Desirable
Higher degree,
e.g. MD/PhD
Experience of clinical
audit
Experience of research
Formal management training
Publications in indexed
journals
Good presentational and
verbal skills
Ability to motivate and
develop medical trainees
Self motivated
Able to work in teams
Ability to work under
pressure
Reliable work record
19
Specialist experience in the
management of breast and
skin malignancies.
PhD/ MD Thesis